These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 37460)

  • 21. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF; Major LF
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotransmitter metabolites in medicated epileptic patients.
    Markianos M; Kalfakis N
    Funct Neurol; 1991; 6(4):367-70. PubMed ID: 1725777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O; Johansson BB; Svennerholm L
    Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA; Bowden CL; Maas JW
    J Chromatogr; 1984 Dec; 336(2):259-69. PubMed ID: 6085084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R; Roos BE; Kampman R; Hyyppä S; Ranta P; Myllylä V
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration gradient of CSF monoamine metabolites in children and adolescents.
    Kruesi MJ; Swedo SE; Hamburger SD; Potter WZ; Rapoport JL
    Biol Psychiatry; 1988 Sep; 24(5):507-14. PubMed ID: 2458775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
    Garrick NA; Seppala T; Linnoila M; Murphy DL
    Eur J Pharmacol; 1985 Mar; 110(1):1-9. PubMed ID: 2408906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.
    Bertilsson L; Asberg M; Lantto O; Scalia-Tomba GP; Träskman-Bendz L; Tybring G
    Psychiatry Res; 1982 Feb; 6(1):77-83. PubMed ID: 6173891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.
    Johansson B; Roos BE
    Acta Neurol Scand; 1975 Aug; 52(2):137-44. PubMed ID: 1155031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):625-9. PubMed ID: 4731331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M; Ninan PT; Scheinin M; Waters RN; Chang WH; Bartko J; van Kammen DP
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
    Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF monoamine metabolites in melancholia.
    Asberg M; Bertilsson L; Mårtensson B; Scalia-Tomba GP; Thorén P; Träskman-Bendz L
    Acta Psychiatr Scand; 1984 Mar; 69(3):201-19. PubMed ID: 6201041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity.
    Sedvall G; Fyrö B; Gullberg B; Nybäck H; Wiesel FA; Wode-Helgodt B
    Br J Psychiatry; 1980 Apr; 136():366-74. PubMed ID: 6155965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
    Degrell I; Nagy E
    Biol Psychiatry; 1990 May; 27(10):1179-82. PubMed ID: 1692743
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; Van Dorth R
    J Affect Disord; 1982 Sep; 4(3):219-26. PubMed ID: 6182175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.